• Bruce G. Haffty, MD

  • An internationally recognized expert in breast radiation oncology, Dr Bruce G. Haffty has forged a legacy as one of the specialty’s premier educators through a lifelong commitment to mentoring, educating, and advising the scores of students fortunate enough to call him teacher. Along with his educational accomplishments, Dr Haffty’s groundbreaking work as a clinician and breast cancer researcher has consistently garnered him national recognition as one of the country’s leading physicians. Dr Haffty’s research has focused on developing new methods for delivering radiation therapy targeting breast cancer and on exploring novel molecular targets that may influence the effectiveness of therapy.

    Dr Haffty completed his medical school training, internal medicine internship, and radiology residency at Yale University School of Medicine in 1988 and spent the next 18 years specializing in breast cancer and head and neck cancer in the Department of Therapeutic R adiology at Yale. Dr Haffty was a professor of therapeutic radiology from 1992 to 2001, residency program director from 1992 through 2004, and vice-chairman and clinical director from 2002 to 2005. He accepted his current positions as professor and chairman of the department of radiation oncology at Robert Wood Johnson Medical School and New Jersey Medical School of Rutgers University, and associate director of clinical sciences at the Cancer Institute of New Jersey, in 2005.

    As director of the residency program at Yale, Dr Haffty personally mentored countless medical students, residents, fellows, and junior attending physicians who went on to carve their own indelible marks within the specialty. He served as the primary thesis advisor for numerous medical students, supervised research projects for countless residents and fellows, and was the primary mentor for many funded trainee grants. Continuing his educational focus at the Robert Wood Johnson Medical School, Dr Haffty spearheaded the expansion of the radiation oncology program and developed a residency program in radiation oncology and medical physics—the only such program in the state of New Jersey.

    Through his extensive work with the American Society for Radiation Oncology (ASTRO), Dr Haffty founded the Association of Directors of Radiation Oncology Programs (ADROP) in 2000, providing tools and resources to advance the quality of residency training and education in radiation oncology. He served as ADROP president from 2000 to 2003 and remains active in the association.

    Dr Haffty has been awarded numerous research grants by various organizations, including the Breast Cancer Research Foundation (BCRF) and the Susan G. Komen Foundation. In a recent BCRF research project, Dr Haffty and colleagues demonstrated that the combination of radiation therapy with BCL-2 inhibitors results in better response rates than radiation therapy alone and discovered molecular pathways of resistance to combined therapy with BCL-2 inhibitors and radiation.

    Dr Haffty has authored or coauthored more than 300 peer-reviewed articles and 30 book chapters and is coeditor of the comprehensiveHandbook of Radiation Oncology. He served as coeditor of the Cancer Journal from 2005 to 2007 and has been associate editor of theJournal of Clinical Oncology since 2007. He has served on the editorial board of the RSNA News since 2009.

    He is a sought-after speaker and has traveled the world as an invited lecturer and visiting professor. In 2009, Dr Haffty delivered the RSNA Annual Oration in Radiation Oncology on “Genetic Factors in the Diagnostic Imaging and Radiotherapeutic Management of Breast Cancer.”

    Among his many national leadership positions, Dr Haffty served as president of the American Board of Radiology (ABR) from 2010 to 2012 and president of the American Radium Society from 2008 to 2009. He chaired the Accreditation Council for Graduate Medical Education (ACGME) Residency Review Committee for Radiation Oncology from 2007 to 2010. Currently, Dr Haffty cochairs the Bolstering Oncoradiologic and Oncoradiotherapeutic Skills for Tomorrow (BOOST) program of the RSNA, which is forging ties between radiology and radiation oncology. He is the current president of ASTRO.

    Dr Haffty was awarded the Leadership in Patient Care Award by the Cancer Institute of New Jersey in 2008 and was the recipient in 2009 of the Norman Edelman Clinical Science Mentoring Award at the Robert Wood Johnson Medical School. Throughout his career, Dr Haffty has been listed consistently as one of the country’s leading physicians by publications including Best Doctors in America, Ladies’ Home Journal, Good Housekeeping, America’s Top Doctors, Top Doctors for Cancer, and Top Doctors in New York and New Jersey.

    In recognition of his remarkable achievements as a mentor, teacher, clinician, and researcher, the RSNA is pleased to name Dr Haffty as its 2013 Outstanding Educator.

We appreciate your comments and suggestions in our effort to improve your RSNA web experience.

Name (required)


Email Address (required)


Comments (required)





Discounted Dues: Eligible North American Countries 
Costa Rica
Dominican Republic
El Salvador
Netherlands Antilles
St. Vincent & Grenadines
Country    Country    Country 
Afghanistan   Grenada   Pakistan
Albania   Guatemala   Papua New Guinea
Algeria   Guinea   Paraguay
Angola   Guinea-Bissau   Peru
Armenia   Guyana   Phillippines
Azerbaijan   Haiti   Rwanda
Bangladesh   Honduras   Samoa
Belarus   India   Sao Tome & Principe
Belize   Indonesia   Senegal
Benin   Iran   Serbia
Bhutan   Iraq   Sierra Leone
Bolivia   Jordan   Solomon Islands
Bosnia & Herzegovina   Jamaica   Somalia
Botswana   Kenya   South Africa
Bulgaria   Kiribati   South Sudan
Burkina Faso   Korea, Dem Rep (North)   Sri Lanka
Burundi   Kosovo   St Lucia
Cambodia   Kyrgyzstan   St Vincent & Grenadines
Cameroon   Laos\Lao PDR   Sudan
Cape Verde   Lesotho   Swaziland
Central African Republic   Liberia   Syria
Chad   Macedonia   Tajikistan
China   Madagascar   Tanzania
Colombia   Malawi   Thailand
Comoros   Maldives   Timor-Leste
Congo, Dem. Rep.   Mali   Togo
Congo, Republic of   Marshall Islands   Tonga
Cote d'Ivoire   Mauritania   Tunisia
Djibouti   Micronesia, Fed. Sts.   Turkmenistan
Dominica   Moldova   Tuvalu
Domicican Republic   Mongolia   Uganda
Ecuador   Montenegro   Ukraine
Egypt   Morocco   Uzbekistan
El Salvador   Mozambique   Vanuatu
Eritrea   Myanmar   Vietnam
Ethiopia   Namibia   West Bank & Gaza
Fiji   Nepal   Yemen
Gambia, The   Nicaragua   Zambia
Georgia   Niger   Zimbabwe
Ghana   Nigeria    

Legacy Collection 2
Radiology Logo
RadioGraphics Logo 
Tier 1

  • Bed count: 1-400
  • Associate College: Community, Technical, Further Education (UK), Tribal College
  • Community Public Library (small scale): general reference public library, museum, non-profit administration office

Tier 2

  • Bed count: 401-750
  • Baccalaureate College or University: Bachelor's is the highest degree offered
  • Master's College or University: Master's is the highest degree offered
  • Special Focus Institution: theological seminaries, Bible colleges, engineering, technological, business, management, art, music, design, law

Tier 3

  • Bedcount: 751-1,000
  • Research University: high or very high research activity without affiliated medical school
  • Health Profession School: non-medical, but health focused

Tier 4

  • Bed count: 1,001 +
  • Medical School: research universities with medical school, including medical centers

Tier 5

  • Consortia: academic, medical libraries, affiliated hospitals, regional libraries and other networks
  • Corporate
  • Government Agency and Ministry
  • Hospital System
  • Private Practice
  • Research Institute: government and non-government health research
  • State or National Public Library
  • Professional Society: trade unions, industry trade association, lobbying organization